会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • ORAL RETRACTOR FOR DENTAL USE
    • 口腔使用的口腔返流器
    • WO2009151268A3
    • 2010-03-11
    • PCT/KR2009003100
    • 2009-06-10
    • SEOUL NAT UNIV IND FOUNDATIONCHUNG CHONG-PYOUNGPARK YOON-JEONGPARK HYUN JUNGKIM JUNG BIN
    • CHUNG CHONG-PYOUNGPARK YOON-JEONGPARK HYUN JUNGKIM JUNG BIN
    • A61C19/00
    • A61B1/24A61C5/90
    • The present invention relates to an oral retractor for dental use, and more particularly, to an oral retractor which has a pair of holders for supporting the lips that are connected to and formed integrally with a support to enable the oral retractor to be easily installed inside a mouth and enable a dentist to diagnose and treat the dental condition of the patient without causing discomfort and damage to the gums and teeth of the patient when installed. The oral retractor for dental use according to the present invention provides convenience for both the patient and the dentist as it is simple to install and further enables the patient to open his/her mouth to an appropriate degree without discomfort, thus ensuring sufficient space for diagnosis and treatment. The oral retractor for dental use according to the present invention can be applied to a variety of oral-related fields as it can be used also for injection of drugs with oral applications.
    • 本发明涉及一种用于牙科用途的口腔牵开器,更具体地说,涉及一种口腔牵开器,其具有一对用于支撑嘴唇的保持器,所述保持器连接并与支撑件一体地形成,从而能够将口腔牵开器容易地安装在内部 口腔,使得牙科诊断和治疗患者的牙齿状况,而不会在安装时引起不适和对患者牙龈的损伤。 根据本发明的用于牙科用途的口腔牵开器为患者和牙医提供了方便,因为其易于安装,并且进一步使得患者能够在适当的程度上打开他/她的口腔而不受到不适,从而确保足够的诊断空间 和治疗。 根据本发明的用于牙科用途的口腔牵开器可以应用于各种口腔相关领域,因为它也可以用于口服应用的药物的注射。
    • 3. 发明申请
    • TARGET ACTIVATED CELL/TISSUE TRANSLOCATION PEPTIDE FOR IMPERMEABLE COMPOUND STRATEGY, AND USES THEREOF
    • 目标活化细胞/组织转移肽用于不可复制的化合物战略及其用途
    • WO2010095881A3
    • 2011-01-06
    • PCT/KR2010001033
    • 2010-02-19
    • UNIV SEOUL NAT R & DB FOUNDNANO INTELLIGENT BIOMED ENGPARK YOON-JEONGCHUNG CHONG-PYOUNGYANG VICTOR C
    • PARK YOON-JEONGCHUNG CHONG-PYOUNGYANG VICTOR C
    • C07K19/00A61K38/17C07K14/47
    • C07K14/47A61K38/00A61K47/645A61K47/65C07K2319/10
    • The present invention relates to a target activated cell/tissue translocation peptide for an impermeable compound strategy (TACTICS), and to uses thereof. More particularly, the present invention relates to a target activated cell/tissue translocation peptide for an impermeable compound strategy (TACTICS), which comprises (a) a protein transport domain (PTD), (B) a masking domain, and (C) a spacer having a target cell/tissue enzyme-specific cleavage, wherein the peptide is provided with selectivity to exhibit translocation performance specifically only in the target tissue. The present invention also relates to an image of the peptide, therapeutic drugs, or a complex of drug-containing grains. The target activated cell/tissue translocation peptide for an impermeable compound strategy-drug complex according to the present invention provides the peptide with target selectivity to obtain the highest quality images and excellent curative effects, and inhibits the unspecific distribution of the complex in the body to minimize side effects and maximize diagnosis effects. Thus, the peptide of the present invention can be valuably used in treating diseases.
    • 本发明涉及用于不可渗透化合物策略(TACTICS)的靶活化细胞/组织易位肽及其应用。 更具体地,本发明涉及用于不可渗透化合物策略(TACTICS)的靶活化细胞/组织易位肽,其包含(a)蛋白质转运结构域(PTD),(B)掩蔽结构域,和(C) 具有靶细胞/组织酶特异性切割的间隔物,其中所述肽具有仅在靶组织中显示易位性能的选择性。 本发明还涉及肽,治疗药物或含药颗粒的复合物的图像。 根据本发明的用于不可渗透化合物策略 - 药物复合物的靶活化细胞/组织易位肽提供具有靶选择性的肽以获得最高质量的图像和优异的疗效,并且抑制复合体在体内的非特异性分布 尽量减少副作用并最大化诊断效果。 因此,本发明的肽可以有价值地用于治疗疾病。
    • 5. 发明申请
    • SURFACE-ACTIVE COLLAGEN BARRIER MEMBRANE TO WHICH A PEPTIDE IS BOUND
    • 表面活性胶原蛋白膜对于肽是有害的
    • WO2012144778A2
    • 2012-10-26
    • PCT/KR2012002895
    • 2012-04-17
    • NANO INTELLIGENT BIOMED ENGCHUNG CHONG-PYOUNGPARK YOON-JEONGLEE JUE-YEONSHIM IN KYONGPARK HYUN JUNG
    • CHUNG CHONG-PYOUNGPARK YOON-JEONGLEE JUE-YEONSHIM IN KYONGPARK HYUN JUNG
    • C07K19/00A61K38/39A61L27/24C07K14/78
    • C07K14/51A61K38/00A61L27/227A61L27/54A61L2300/25A61L2300/412C07K14/4723C07K14/485C07K14/49C07K14/78C07K2319/00
    • The present invention relates to a barrier membrane to which a peptide, which binds to collagen and which is capable of regenerating bone tissue, is bound. More particularly, the present invention relates to a collagen barrier membrane in which a fusion peptide consisting of a collagen-bound peptide and a functional bone-tissue-regenerating peptide is fixed to the surface of collagen. According to the present invention, the surface-active collagen barrier membrane, in which a fusion peptide is coupled to the surface of collagen, can stably bind to the body due to increased local retention, and promote the transport, proliferation, and differentiation of cells, to thereby ultimately maximize bone-tissue-regenerating capacity when implanted in the body. Therefore, the barrier membrane of the present invention is useful in the development of guided bone-regeneration technology. In addition, a fusion peptide can be applied to implants made of collagen having other shapes, and a collagen-bound peptide, which constitutes the fusion peptide, can be bound to and synthesized with a peptide having effects in regenerating other tissue, and therefore can be useful in tissue-regenerating biomaterials for other purposes, e.g. for regenerating skin.
    • 本发明涉及一种与胶原结合且能够再生骨组织的肽结合的阻隔膜。 更具体地说,本发明涉及胶原屏障膜,其中由胶原结合肽和功能性骨组织再生肽组成的融合肽固定在胶原蛋白表面。 根据本发明,融合肽与胶原表面偶联的表面活性胶原屏障膜可以由于局部保留的增加而稳定地结合身体,促进细胞的转运,增殖和分化 ,从而最终使植入体内的骨组织再生能力最大化。 因此,本发明的阻隔膜可用于引导骨再生技术的开发。 此外,融合肽可以应用于具有其他形状的胶原的植入物,并且构成融合肽的胶原结合肽可以与具有再生其他组织的肽结合并合成,因此可以 用于组织再生生物材料用于其他目的,例如 用于再生皮肤。